Aristolochia brevipes
Aristolochia brevipes · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Aristolochia brevipes is a unique herbaceous plant belonging to the widely studied birthwort family. This species is of particular interest to researchers due to its specialized phytochemical profile. One notable chemical constituent found within the plant is 9-methoxytariacuripyrone. Studying these specific compounds helps scientists understand the complex biological activities inherent to the genus. Consequently, this plant serves as an important subject in the ongoing investigation of natural product chemistry.
- Synonyms
- Aristolochia Subclausa · Einomeia Brevipes
- Common names
- Not available
- Family
- Aristolochiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Aristolochia brevipes is a botanical species that is frequently identified through various taxonomic designations. Within scientific literature, this plant is recognized by the synonym Aristolochia subclausa. Researchers also refer to the same organism using the alternative name Einomeia brevipes. These overlapping nomenclatures highlight the complex history of botanical classification and naming conventions. Understanding these relationships is essential for accurate identification in both field studies and herbarium records.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aristolochia brevipes belongs to the vast kingdom Plantae, representing a unique branch of the natural world. Within this kingdom, the species is classified under the class Equisetopsida, highlighting its structural characteristics. It further resides in the order Piperales, which connects it to a specific lineage of flowering plants. As a member of the family Aristolochiaceae, it shares evolutionary traits with its close botanical relatives. Ultimately, this plant is defined by its placement within the genus Aristolochia, anchoring its identity in biological taxonomy.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Piperales |
| Family | Aristolochiaceae |
| Genus | Aristolochia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aristolochia brevipes is a plant species with a broad geographic presence across North America. Within the country of Mexico, its reach is particularly extensive and diverse. The species can be found inhabiting the central regions as well as the northeastern territories. Furthermore, its distribution extends into the northwest and southwest portions of the nation. This wide-ranging habitat highlights the adaptability of the plant across various Mexican landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aristolochia brevipes is characterized by an obligatory climbing habit, meaning it relies entirely on external structures for support to reach the light.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Aristolochia brevipes stands out as one of the most potent plant extracts evaluated for its antimycobacterial activity against tuberculosis. Researchers have identified several active compounds within this species that contribute to its medicinal potential. Specifically, the plant contains 9-methoxytariacuripyrone, which serves as a precursor to a highly active chemical derivative. This transformation product exhibits significant inhibitory effects, demonstrating a potency that is only slightly lower than the reference drug Rifampicin. Given these findings, further clinical trials are necessary to fully explore the therapeutic value of this compound against resistant drug strains.
Conditions
Aristolochia brevipes serves as a significant component in Mexican traditional medicine for addressing respiratory conditions. Within the reviewed species, this plant stands out as the most potent extract for antimycobacterial activity. Specifically, its extracts demonstrated a minimum inhibitory concentration of 12.5 µg/mL against tested strains. Furthermore, a transformation product isolated from the plant showed even greater potency with an MIC of 3.125 µg/mL. These findings highlight its potential as a promising drug lead for treating tuberculosis and related ailments.